HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

William J Sandborn Selected Research

Inflammatory Bowel Diseases (Inflammatory Bowel Disease)

12/2015New Applications for Traditional Drugs in Inflammatory Bowel Disease: What Do Cochrane Reviews Tell Us?
6/2015C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis.
6/2015Biologic concentration testing in inflammatory bowel disease.
3/2015A gp130-Src-YAP module links inflammation to epithelial regeneration.
1/2015Role for therapeutic drug monitoring during induction therapy with TNF antagonists in IBD: evolution in the definition and management of primary nonresponse.
11/2014Proactive therapeutic concentration monitoring of infliximab may improve outcomes for patients with inflammatory bowel disease: results from a pilot observational study.
11/2014Tumor necrosis factor-alpha antagonists twenty years later: what do Cochrane reviews tell us?
11/2014Four-year maintenance treatment with adalimumab in patients with moderately to severely active ulcerative colitis: Data from ULTRA 1, 2, and 3.
9/2014Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases.
9/2014Update on Janus kinase antagonists in inflammatory bowel disease.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


William J Sandborn Research Topics

Disease

119Crohn Disease (Crohn's Disease)
01/2016 - 01/2002
78Ulcerative Colitis
01/2016 - 04/2002
43Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
12/2015 - 01/2002
20Infection
03/2015 - 12/2002
15Inflammation
05/2015 - 05/2002
10Colitis
08/2013 - 04/2002
9Fistula
01/2012 - 12/2002
8Necrosis
05/2015 - 02/2003
7Neoplasms (Cancer)
05/2015 - 04/2002
7Body Weight (Weight, Body)
03/2014 - 11/2004
7Delayed Hypersensitivity (Hypersensitivity, Type IV)
05/2010 - 05/2002
6Colorectal Neoplasms (Colorectal Cancer)
03/2015 - 01/2006
6Tuberculosis (Tuberculoses)
01/2014 - 12/2002
5Hemorrhage
04/2015 - 12/2005
5Pouchitis
01/2015 - 04/2002
5Lymphoma (Lymphomas)
06/2013 - 01/2002
4Sepsis (Septicemia)
01/2014 - 04/2009
3Proctitis
11/2015 - 05/2012
3Multiple Sclerosis
08/2015 - 01/2004
3Disease Progression
12/2013 - 02/2006
3Microscopic Colitis
02/2013 - 01/2006
3Abscess
04/2012 - 12/2008
3Demyelinating Diseases (Demyelinating Disease)
09/2011 - 01/2004
3Rheumatoid Arthritis
09/2011 - 05/2002
3Hypersensitivity (Allergy)
08/2010 - 10/2004
3Leukopenia
01/2010 - 07/2003
2Proctocolitis (Hemorrhagic Proctocolitis)
11/2015 - 04/2015
2Psoriasis (Pustulosis Palmaris et Plantaris)
05/2015 - 01/2011
2Heart Failure
01/2014 - 09/2007
2Headache (Headaches)
08/2013 - 08/2003
2Progressive Multifocal Leukoencephalopathy
11/2012 - 11/2005
2Pyoderma Gangrenosum
05/2012 - 01/2011
2Pneumonia (Pneumonitis)
09/2011 - 04/2009
2Colonic Diseases
04/2011 - 01/2002
2Ankylosing Spondylitis
01/2011 - 02/2003
2Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
01/2009 - 06/2003
2Diarrhea
08/2006 - 11/2002
1Meningitis
11/2015
1Lupus Nephritis
08/2015
1Huntington Disease (Huntington's Disease)
08/2015
1Soft Tissue Infections
05/2015

Drug/Important Bio-Agent (IBA)

55infliximab (Remicade)FDA Link
10/2015 - 05/2002
43Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2015 - 05/2002
29adalimumab (Humira)FDA Link
01/2016 - 02/2003
21Mesalamine (Mesalazine)FDA LinkGeneric
11/2014 - 01/2002
19Azathioprine (Imuran)FDA LinkGeneric
03/2015 - 01/2002
18CDP870FDA Link
08/2015 - 02/2003
16Adrenal Cortex Hormones (Corticosteroids)IBA
07/2013 - 08/2002
14Budesonide (Pulmicort)FDA LinkGeneric
11/2015 - 01/2002
136-Mercaptopurine (Mercaptopurine)FDA LinkGeneric
07/2014 - 01/2002
10C-Reactive ProteinIBA
06/2015 - 12/2003
9Biological Markers (Surrogate Marker)IBA
03/2015 - 07/2003
8Immunosuppressive Agents (Immunosuppressants)IBA
09/2014 - 05/2004
7AntibodiesIBA
10/2015 - 02/2003
7Interleukin-12 (IL 12)IBA
06/2015 - 05/2002
7natalizumab (Tysabri)FDA Link
11/2012 - 05/2002
5vedolizumabIBA
11/2015 - 08/2013
5Monoclonal AntibodiesIBA
04/2014 - 05/2002
5Primary sclerosing cholangitisIBA
04/2013 - 12/2008
5SteroidsIBA
02/2012 - 09/2002
5Sulfasalazine (Azulfidine)FDA LinkGeneric
04/2010 - 01/2002
4Leukocyte L1 Antigen Complex (Calgranulin)IBA
01/2016 - 11/2008
4golimumabFDA Link
05/2015 - 01/2014
4Ciprofloxacin (Cipro)FDA LinkGeneric
01/2015 - 01/2009
4Phosphotransferases (Kinase)IBA
09/2014 - 02/2003
4monoclonal antibody CNTO 1275 (CNTO 1275)FDA Link
10/2012 - 10/2008
4Phenobarbital (Luminal)FDA Link
04/2012 - 05/2006
4recombinant human tumor necrosis factor-binding protein-1IBA
07/2006 - 05/2002
4TNFR-Fc fusion protein (etanercept)FDA Link
01/2005 - 05/2002
3LactoferrinIBA
06/2015 - 06/2003
3Metronidazole (Metric)FDA LinkGeneric
01/2015 - 01/2009
3Prednisone (Sone)FDA LinkGeneric
02/2013 - 05/2006
3Immunologic Factors (Immunomodulators)IBA
07/2012 - 12/2008
3Methotrexate (Mexate)FDA LinkGeneric
12/2011 - 12/2002
3visilizumabIBA
11/2010 - 04/2009
2CytokinesIBA
02/2015 - 10/2008
2Anti-Bacterial Agents (Antibiotics)IBA
01/2015 - 01/2010
2Carbon MonoxideIBA
04/2014 - 01/2007
2Serum AlbuminIBA
01/2014 - 04/2012
2Cyclosporine (Ciclosporin)FDA LinkGeneric
12/2012 - 06/2004
2Interleukin-23 (Interleukin 23)IBA
10/2012 - 10/2008
2Narcotics (Narcotic Analgesics)IBA
09/2012 - 05/2009
2Estrogens (Estrogen)FDA Link
07/2010 - 11/2003
2rifaximin (L 105)FDA Link
01/2010 - 10/2007
2Integrin alpha4IBA
12/2007 - 05/2002
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
06/2006 - 11/2002
2Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
02/2006 - 04/2002
2celecoxib (Celebrex)FDA Link
02/2006 - 04/2002
2InterferonsIBA
01/2005 - 01/2004
2Tacrolimus (Prograf)FDA LinkGeneric
06/2004 - 08/2003
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2004 - 05/2002
1laquinimodIBA
08/2015
1briakinumabIBA
06/2015

Therapy/Procedure

13Biological Therapy
11/2012 - 05/2002
9Colectomy
05/2015 - 04/2002
8Remission Induction
11/2015 - 01/2002
4Drug Therapy (Chemotherapy)
12/2015 - 12/2005
4Blood Component Removal (Apheresis)
08/2008 - 12/2005
2Aftercare (After-Treatment)
02/2015 - 10/2009
1Photochemotherapy (Photodynamic Therapy)
05/2015